Showing results (41-50 of 714) with videos related to
Sort By:
Pageof 72
Expert Opinion on Investigational Drugs|September 23, 2006
Intensive statin therapy for treating acute coronary syndromesKausik K Ray, Christopher P CannonCurrent Opinion in Lipidology|November 11, 2006
The safety and efficacy of achieving very low LDL-cholesterol concentrations with high dose statin therapyStephen D Wiviott, Christopher P CannonFuture Cardiology|October 7, 2009
A point-of-care assay to measure platelet aggregation in patients taking clopidogrelDalton S McLean, Christopher P CannonThe American Journal of Managed Care|April 27, 2011
New options for stroke prevention in atrial fibrillationChristopher P Cannon, Eric C SteckerThe American Journal of Cardiology|August 30, 2005
Early time to benefit with intensive statin treatment: could it be the pleiotropic effects?Kausik K Ray, Christopher P CannonCurrent Opinion in Cardiology|October 20, 2005
Optimal goals for statin use in patients with coronary artery diseaseKausik K Ray, Christopher P CannonClinical Cardiology|July 23, 2013
Triple oral antithrombotic therapy in atrial fibrillation and coronary artery stentingGrant W Reed, Christopher P CannonClinical Cardiology|March 8, 2018
PCSK9 inhibitor valuation: A science-based review of the two recent modelsSeth J Baum, Christopher P CannonThe American Journal of Cardiology|December 25, 2007
Cannabinoid-1 receptor blockade in cardiometabolic risk reduction: safety, tolerability, and therapeutic potentialBenjamin A Steinberg, Christopher P CannonCurrent Opinion in Lipidology|November 6, 2004
Intensive statin therapy in acute coronary syndromes: clinical benefits and vascular biologyKausik K Ray, Christopher P CannonPageof 72